Clinical and radiological outcome of patients suffering from chronic pancreatitis associated with gene mutations

Pancreas. 2008 Nov;37(4):371-6. doi: 10.1097/MPA.0b013e31817f52a1.

Abstract

Objectives: Cystic fibrosis transmembrane conductance regulator (CFTR), cationic trypsinogen gene (PRSS1), and serine protease inhibitor kazal type 1 (SPINK1) gene mutations have been associated with chronic pancreatitis (CP). The aim of this study was to compare clinical and radiological findings in sporadic CP with (CPgm) and without (CPwt) gene mutations.

Methods: Data from patients observed between 2001 and 2006 were collected. All patients were tested for 25 CFTR gene mutations, for R122H and N29I on the PRSS1 gene, and for N34S mutation on the SPINK1 gene.

Results: We found 34 (17.2%) of 198 patients with CPgm, 23 (11.6%) of them on the CFTR gene, 11 (5.6%) on the SPINK1, and none on the PRSS1 gene. The age at clinical onset was younger in CPgm (36.2 +/- 17.2 years) than in CPwt (44 +/- 12.6 years; P = 0.005). There were more heavy drinkers among CPwt (33%) than among CPgm (9%; P = 0.003), and the same applied to smokers (69% vs 33%, respectively; P < 0.0001). In CPgm group, the onset of pancreatic calcifications was observed more frequently in drinkers and/or smokers. Exocrine and endocrine insufficiency occurred less frequently and later in CPgm than in CPwt patients.

Conclusions: Clinical and radiological outcome differ in CPgm compared with CPwt. Alcohol, even in small quantities, and cigarette smoking influence the onset of pancreatic calcifications.

MeSH terms

  • Adult
  • Age Factors
  • Alcohol Drinking / adverse effects
  • Carrier Proteins / genetics*
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Pancreatitis, Chronic / complications
  • Pancreatitis, Chronic / diagnostic imaging
  • Pancreatitis, Chronic / genetics*
  • Pancreatitis, Chronic / surgery
  • Prospective Studies
  • Radiography
  • Risk Factors
  • Smoking / adverse effects
  • Time Factors
  • Treatment Outcome
  • Trypsin
  • Trypsin Inhibitor, Kazal Pancreatic
  • Trypsinogen / genetics*
  • Young Adult

Substances

  • CFTR protein, human
  • Carrier Proteins
  • SPINK1 protein, human
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Trypsin Inhibitor, Kazal Pancreatic
  • Trypsinogen
  • PRSS1 protein, human
  • Trypsin